795 related articles for article (PubMed ID: 26845192)
1. The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer.
Bremnes RM; Busund LT; Kilvær TL; Andersen S; Richardsen E; Paulsen EE; Hald S; Khanehkenari MR; Cooper WA; Kao SC; Dønnem T
J Thorac Oncol; 2016 Jun; 11(6):789-800. PubMed ID: 26845192
[TBL] [Abstract][Full Text] [Related]
2. Immune Cell Composition in Human Non-small Cell Lung Cancer.
Stankovic B; Bjørhovde HAK; Skarshaug R; Aamodt H; Frafjord A; Müller E; Hammarström C; Beraki K; Bækkevold ES; Woldbæk PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
Front Immunol; 2018; 9():3101. PubMed ID: 30774636
[TBL] [Abstract][Full Text] [Related]
3. The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer.
Bremnes RM; Al-Shibli K; Donnem T; Sirera R; Al-Saad S; Andersen S; Stenvold H; Camps C; Busund LT
J Thorac Oncol; 2011 Apr; 6(4):824-33. PubMed ID: 21173711
[TBL] [Abstract][Full Text] [Related]
4. Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade.
Biton J; Ouakrim H; Dechartres A; Alifano M; Mansuet-Lupo A; Si H; Halpin R; Creasy T; Bantsimba-Malanda C; Arrondeau J; Goldwasser F; Boudou-Rouquette P; Fournel L; Roche N; Burgel PR; Goc J; Devi-Marulkar P; Germain C; Dieu-Nosjean MC; Cremer I; Herbst R; Damotte D
Am J Respir Crit Care Med; 2018 Oct; 198(7):928-940. PubMed ID: 29518341
[TBL] [Abstract][Full Text] [Related]
5. The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome.
Remark R; Becker C; Gomez JE; Damotte D; Dieu-Nosjean MC; Sautès-Fridman C; Fridman WH; Powell CA; Altorki NK; Merad M; Gnjatic S
Am J Respir Crit Care Med; 2015 Feb; 191(4):377-90. PubMed ID: 25369536
[TBL] [Abstract][Full Text] [Related]
6. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
Perea F; Bernal M; Sánchez-Palencia A; Carretero J; Torres C; Bayarri C; Gómez-Morales M; Garrido F; Ruiz-Cabello F
Int J Cancer; 2017 Feb; 140(4):888-899. PubMed ID: 27785783
[TBL] [Abstract][Full Text] [Related]
7. Antigen-Presenting Intratumoral B Cells Affect CD4
Bruno TC; Ebner PJ; Moore BL; Squalls OG; Waugh KA; Eruslanov EB; Singhal S; Mitchell JD; Franklin WA; Merrick DT; McCarter MD; Palmer BE; Kern JA; Slansky JE
Cancer Immunol Res; 2017 Oct; 5(10):898-907. PubMed ID: 28848053
[TBL] [Abstract][Full Text] [Related]
8. Composition of the immune microenvironment differs between carcinomas metastatic to the lungs and primary lung carcinomas.
Senarathne W; Vranic S; Xiu J; Rose I; Gates P; Gatalica Z
Ann Diagn Pathol; 2018 Apr; 33():62-68. PubMed ID: 29566951
[TBL] [Abstract][Full Text] [Related]
9. Metastatic spread in patients with non-small cell lung cancer is associated with a reduced density of tumor-infiltrating T cells.
Müller P; Rothschild SI; Arnold W; Hirschmann P; Horvath L; Bubendorf L; Savic S; Zippelius A
Cancer Immunol Immunother; 2016 Jan; 65(1):1-11. PubMed ID: 26541588
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
[TBL] [Abstract][Full Text] [Related]
11. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.
Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y
Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710
[TBL] [Abstract][Full Text] [Related]
12. Designed Methods for the Sorting of Tertiary Lymphoid Structure-Immune Cell Populations.
Devi-Marulkar P; Kaplon H; Dieu-Nosjean MC; Lawand M
Methods Mol Biol; 2018; 1845():189-204. PubMed ID: 30141014
[TBL] [Abstract][Full Text] [Related]
13. Cancer immune contexture and immunotherapy.
Becht E; Giraldo NA; Dieu-Nosjean MC; Sautès-Fridman C; Fridman WH
Curr Opin Immunol; 2016 Apr; 39():7-13. PubMed ID: 26708937
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer.
Yan X; Jiao SC; Zhang GQ; Guan Y; Wang JL
Cancer Gene Ther; 2017 Feb; 24(2):57-63. PubMed ID: 28084319
[TBL] [Abstract][Full Text] [Related]
15. A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment.
Mediavilla-Varela M; Castro J; Chiappori A; Noyes D; Hernandez DC; Allard B; Stagg J; Antonia SJ
Neoplasia; 2017 Jul; 19(7):530-536. PubMed ID: 28582704
[TBL] [Abstract][Full Text] [Related]
16. Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer.
Donnem T; Kilvaer TK; Andersen S; Richardsen E; Paulsen EE; Hald SM; Al-Saad S; Brustugun OT; Helland A; Lund-Iversen M; Solberg S; Gronberg BH; Wahl SG; Helgeland L; Fløtten O; Pohl M; Al-Shibli K; Sandanger TM; Pezzella F; Busund LT; Bremnes RM
Ann Oncol; 2016 Feb; 27(2):225-32. PubMed ID: 26578726
[TBL] [Abstract][Full Text] [Related]
17. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression.
Kataki A; Scheid P; Piet M; Marie B; Martinet N; Martinet Y; Vignaud JM
J Lab Clin Med; 2002 Nov; 140(5):320-8. PubMed ID: 12434133
[TBL] [Abstract][Full Text] [Related]
18. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
Tao H; Mimura Y; Aoe K; Kobayashi S; Yamamoto H; Matsuda E; Okabe K; Matsumoto T; Sugi K; Ueoka H
Lung Cancer; 2012 Jan; 75(1):95-101. PubMed ID: 21719142
[TBL] [Abstract][Full Text] [Related]
19. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
20. Relationship of dendritic cell density, HMGB1 expression, and tumor-infiltrating lymphocytes in non-small cell lung carcinomas.
Aguilar-Cazares D; Meneses-Flores M; Prado-Garcia H; Islas-Vazquez L; Rojo-Leon V; Romero-Garcia S; Rivera-Rosales RM; Lopez-Gonzalez JS
Appl Immunohistochem Mol Morphol; 2014; 22(2):105-13. PubMed ID: 24752173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
